C07H 19/052
Imidazole radicals
C07H19/052 (Imidazole radicals) appears on 186 US grants and 118 published applications in this corpus.
Search patents in C07H- Granted patents
- 186
- Published applications
- 118
- Assignees
- 92
- Inventors
- 353
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 7 | 0 |
| 1992 | 5 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 14 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 5 | 4 |
| 2002 | 10 | 4 |
| 2003 | 3 | 9 |
| 2004 | 2 | 9 |
| 2005 | 7 | 5 |
| 2006 | 3 | 3 |
| 2007 | 3 | 2 |
| 2008 | 4 | 6 |
| 2009 | 5 | 5 |
| 2010 | 2 | 2 |
| 2011 | 1 | 4 |
| 2012 | 1 | 2 |
| 2013 | 4 | 8 |
| 2014 | 5 | 2 |
| 2015 | 6 | 2 |
| 2016 | 0 | 4 |
| 2017 | 2 | 6 |
| 2018 | 2 | 2 |
| 2019 | 1 | 4 |
| 2020 | 2 | 4 |
| 2021 | 5 | 4 |
| 2022 | 1 | 3 |
| 2023 | 2 | 2 |
| 2024 | 5 | 11 |
| 2025 | 7 | 6 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Adenosine analog and its use in regulating the circadian clock30 Jun 2026US 12,667,584 B2National Institute of Biological Sciences, Beijing
- Stable heavy isotopes in amide functional groups and uses thereof7 Apr 2026US 12,595,260 B2Risen (Suzhou) Pharma Tech Co., Ltd.
- Viral inhibitors, the synthesis thereof, and intermediates thereto20 Jan 2026US 12,527,771 B2Takeda Pharmaceutical Company Limited
- Ectonucleotidase inhibitors and methods of use thereof23 Sep 2025US 12,421,273 B2Antengene Therapeutics Limited
- Galactoside inhibitor of galectins9 Sep 2025US 12,410,207 B2Galecto Biotech AB
- Adenosine analog and its use in regulating the circadian clock1 Oct 2026US 2026/0294952 A1National Institute of Biological Sciences, Beijing
- Viral inhibitors, the synthesis therof, and intermediates thereto23 Apr 2026US 2026/0108495 A1Takeda Pharmaceutical Company Limited
- Viral inhibitors, the synthesis thereof, and intermediates thereto9 Apr 2026US 2026/0097018 A1Takeda Pharmaceutical Company Limited
- Viral inhibitors, the synthesis thereof, and intermediates thereto19 Mar 2026US 2026/0076945 A1Takeda Pharmaceutical Company Limited
- Viral inhibitors, the synthesis thereof, and intermediates thereto19 Mar 2026US 2026/0076946 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Nucleic acid analysis techniques405US 6,344,316 B12002
- 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines280US 5,268,376 AMinnesota Mining and Manufacturing Company · 1993
- 1-substituted 1H-imidazo-[4,5-C]quinolin-4-amines275US 5,346,905 AMinnesota Mining and Manufacturing Company · 1994
- 1-substituted 1H-imidazo-[4,5-c]quinolin-4-amines134US 5,525,612 AMinnesota Mining and Manufacturing Company · 1996
- Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes128US 5,767,097 AICN Pharmaceuticals, Inc. · 1998